Microalbuminuria has been shown to be a risk factor for adverse renal and cardiovascular outcomes in patients with diabetes
mellitus. This risk appears to increase with higher levels of albuminuria. There is also evidence that reducing the level
of albuminuria improves these outcomes. This review focuses on the most recent advances in this area and reviews literature
over the past year on this topic.